Lucid Diagnostics Inc.LUCDNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+381.0%
5Y CAGR+197.9%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+381.0%/yr
vs +100.1%/yr prior
5Y CAGR
+197.9%/yr
Recent acceleration
Acceleration
+280.9pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
234.5x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$1.28B+21197.3%
2024$5.99M-17.4%
2023$7.25M-36.8%
2022$11.47M+23.3%
2021$9.30M+70.8%
2020$5.44M+57.2%
2019$3.46M+383.8%
2018$715629.00-